G9847 HCPCS Level II code: Patient received systemic cancer-directed therapy in the last 14 days of life
G9847 is the HCPCS code for “Patient received systemic cancer-directed therapy in the last 14 days of life” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
G9847Patient received systemic cancer-directed therapy in the last 14 days of life
Short description: Pt recd chemo last 14d life
HCPCS · United States
Medicare details
The indicators CMS publishes with G9847 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care
- BETOS category
- Undefined codes
- Added
- Jan 1, 2017
Where G9847 sits
- 1G codesProcedures and professional services
- 2Active code G9847Patient received systemic cancer-directed therapy in the last 14 days of life
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code G9847 mean?
G9847 is the HCPCS code for “Patient received systemic cancer-directed therapy in the last 14 days of life” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover G9847?
CMS lists G9847’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside G9847
All G codesG9841Ras (kras and nras) gene mutation testing not performed before initiation of anti-egfr moabG9842Patient has metastatic disease at diagnosisG9843Ras (kras or nras) gene mutationG9844Patient did not receive anti-egfr monoclonal antibody therapyG9845Patient received anti-egfr monoclonal antibody therapyG9846Patients who died from cancerG9848Patient did not receive systemic cancer-directed therapy in the last 14 days of lifeG9849Patients who died from cancerG9850Patient had more than one emergency department visit in the last 30 days of lifeG9851Patient had one or less emergency department visits in the last 30 days of lifeG9852Patients who died from cancerG9853Patient admitted to the icu in the last 30 days of life